COHERUS BIOSCIENCES I
0.8200
07-11月-24 15:59:58
15 分の遅延
株式
+0.0962
+13.29%
本日の幅
0.7610 - 0.9550
ISIN
N/A
ソース
NASDAQ
-
Coherus Prices Public Offering of Common Stock
16 5 2023 06:50:00 提供 Nasdaq GlobeNewswire
-
Coherus Announces Proposed Public Offering of Common Stock
15 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
08 5 2023 16:05:02 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in May
04 5 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
01 5 2023 16:07:00 提供 Nasdaq GlobeNewswire
-
27 4 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
06 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
FDA Approves UDENYCA® Autoinjector
06 3 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in March
01 3 2023 08:25:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
28 2 2023 08:25:00 提供 Nasdaq GlobeNewswire
-
13 2 2023 08:25:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
03 2 2023 17:30:09 提供 Nasdaq GlobeNewswire
-
09 1 2023 08:20:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 1 2023 07:01:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
08 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
01 11 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
12 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United States on October 3, 2022
19 9 2022 07:30:00 提供 Nasdaq GlobeNewswire